Antidiabetic Properties of Rose Hip
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Rose hip
Sponsored by

About this trial
This is an interventional treatment trial for Obesity focused on measuring obesity, glucose intolerance, cholesterol, blood pressure
Eligibility Criteria
Inclusion Criteria:
- BMI > 30
- willingness to participate in the study
- willingness to comply with the daily intake of drinks and the recommended energy intake during the course of the study
Exclusion Criteria:
- diabetes
- previous or ongoing insulin treatment
- abnormal thyroid status
- abnormal liver status
- abnormal kidney status
- known gastrointestinal disorder
- pregnancy
- suspected allergy to ingredients of the drinks
Sites / Locations
- Endocrinology Clinic, Lund University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Rose hip
Arm Description
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01316016
Brief Title
Antidiabetic Properties of Rose Hip
Official Title
Effects of Rose Hip Intake on Risk Markers of Type 2 Diabetes and Cardiovascular Disease: a Randomized Double-blind Cross-over Investigation in Obese Persons
Study Type
Interventional
2. Study Status
Record Verification Date
February 2011
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
January 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Lund University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, glucose intolerance, cholesterol, blood pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Rose hip
Arm Type
Experimental
Intervention Type
Dietary Supplement
Intervention Name(s)
Rose hip
Intervention Description
40 g of rose hip powder daily for 6 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
BMI > 30
willingness to participate in the study
willingness to comply with the daily intake of drinks and the recommended energy intake during the course of the study
Exclusion Criteria:
diabetes
previous or ongoing insulin treatment
abnormal thyroid status
abnormal liver status
abnormal kidney status
known gastrointestinal disorder
pregnancy
suspected allergy to ingredients of the drinks
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Per Katzman, MD/PhD
Organizational Affiliation
Lund University
Official's Role
Study Chair
Facility Information:
Facility Name
Endocrinology Clinic, Lund University Hospital
City
Lund
ZIP/Postal Code
SE-22185
Country
Sweden
12. IPD Sharing Statement
Citations:
PubMed Identifier
20959531
Citation
Andersson U, Henriksson E, Strom K, Alenfall J, Goransson O, Holm C. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E111-21. doi: 10.1152/ajpendo.00268.2010. Epub 2010 Oct 19.
Results Reference
background
Learn more about this trial
Antidiabetic Properties of Rose Hip
We'll reach out to this number within 24 hrs